NEWS
The power of vaccines in the fight against AMR
A newly published article from the Microbiology Society highlights actions which could help realise the full potential of vaccines in tackling antimicrobial resistance. Published in the Microbiology Society’s
Journal of Medical Microbiology, ‘Impact of vaccines on antimicrobial resistance’ has been produced as the result of a working group created as part of the Society’s Knocking Out AMR campaign. Antimicrobial resistance (AMR) is one of the most pressing global health threats of our time, undermining the efficacy of life-saving treatments and placing a
Clinisys acquires Orchard Software
Clinisys has announced the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specialises in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements.
The companies’ combined capabilities
provide for comprehensive, flexible, and scalable informatics offerings that can better serve customers across the global diagnostics market. “We are excited to welcome Orchard to the Clinisys family,” said Michael Simpson, Clinisys’s CEO. “As a global leader in laboratory informatics, with over 45 years of domain experience, Clinisys has a clear strategy to create and deliver the next evolution of cloud-based laboratory solutions. As we continue to pursue excellence in developing both our world class solutions and our industry expertise, expanding with Orchard’s proven solution in the physician office, reference, and veterinary laboratory space was a clear decision for us.” Francisco Partners acquired Orchard
Software in 2019 and has since modernised its product suite, enhanced its cloud solutions, and strengthened its leadership team. The combination of Orchard’s LIS portfolio and Clinisys’s LIMS and diagnostic solutions creates new opportunities for customers across North America and international markets.
WWW.PATHOLOGYINPRACTICE.COM SEPTEMBER 2025 11
growing burden on health systems worldwide. While vaccines are recognised for their ability to prevent infections and reduce antibiotic use, thereby slowing the emergence of resistance, their role in addressing AMR remains underexploited in both policy and practice. To address this gap, the Microbiology Society convened a workshop bringing together 21 expert stakeholders across academia, industry, policy and the clinical and veterinary sectors. Key themes emerged from the
workshop, including the urgent need to strengthen the evidence base for vaccine- mediated AMR reduction, removing policy and regulatory barriers that limit vaccine deployment in AMR strategies and creating incentives for public- private collaboration in vaccine development. To realise the full potential of vaccines in tackling AMR, the workshop identified five critical
areas for coordinated action: integrating AMR into vaccine policies; incentivising and supporting the inclusion of AMR reduction as a defined endpoint in clinical trials; strengthening data and modelling; fostering cross-sector partnerships, and clearly labelling AMR benefits. n Dougan G, Hugo-Webb E. Impact of vaccines on antimicrobial resistance. J Med Microbiol. 2025;74(8):10.1099/ jmm.0.002050. doi:10.1099/jmm.0.002050
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
